CLOs on the Move

Canadian Aboriginal AIDS Network

www.caan.ca

 
Canadian Aboriginal AIDS Network is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.caan.ca

  • Vancouver, BC CAN V6N 2C7
  • Phone: 604.266.7616

Executives

Name Title Contact Details

Similar Companies

1life Healthcare Inc

1life Healthcare Inc is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

IDLife Corporate

IDLife stands for “Individually Designed Life.” You really can have the best health you’ve ever experienced, the income you’ve always desired and the lifestyle you deserve. Healthy Simplified.

Healthcare Interactive

Healthcare Interactive, Inc. (HCIactive) is dedicated to revolutionizing the administration and delivery of healthcare. Through our patented, integrative technology and supplemental ancillary services, we afford clients the freedom, control and energy to provide high-performance plan solutions that mitigate risk and improve member outcomes. Disparate plan functions, such as enrollment and eligibility, incentive management and population health are seamlessly conducted through our single-source, cloud-based platform. The outcome: greater operational efficiency, actionable performance data, increased member participation, and overall reduced healthcare costs. Founded in 2006, HCIactive is the progressive leader in delivering integrated, health plan solutions to TPA`s, brokers, health systems, providers and their customers. Our executive leadership team is comprised of seasoned professionals who have established successful track-records in the healthcare industry with over 85 years of combined experience.

American Healthguard Dental Plan

American Healthguard Dental Plan is a Arcadia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hemispherx Biopharma

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.